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Background: Malnutrition is a widespread problem in elderly people and is associated with cognitive decline.
However, interventional studies have produced ambiguous results. For this reason, we wanted to determine the
effect of micronutrient supplementation on blood and tissue levels and on general nutritional status in persons
with mild or moderate cognitive impairment.
Methods: We performed a 2-month, open-label trial, administering a daily micronutrient supplement to 42 memory
clinic patients with mild cognitive deficits. Blood levels of antioxidants, zinc, and B vitamins were determined before
and after supplementation. In addition, we assessed metabolic markers for B vitamins and intracellular (buccal mucosa
cell [BMC]) antioxidant levels. Nutritional status was assessed by using the Mini Nutritional Assessment (MNA).
Results: Blood levels of B vitamins, folic acid, lutein, β-carotene, α-carotene, and α-tocopherol increased significantly.
Decreases in homocysteine levels and the thiamine pyrophosphate effect and an increase in holotranscobalamin were
observed. We found no increase in intracellular antioxidant levels of BMC. The MNA score in subjects at risk for
malnutrition increased significantly, mainly owing to better perception of nutritional and overall health status.
Conclusions: Micronutrient supplementation improved serum micronutrient status, with improved metabolic markers
for B vitamins but not for intracellular antioxidant status, and was associated with improved self-perception of general
health status. Our data underline the necessity of determining micronutrient status and support the use of additional
assessments for general health and quality of life in nutritional supplementation trials.
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The aging population is increasing, and the risk of malnu-
trition increases with age [1]. As such, nutrition and nutri-
tional supplementation for this population are becoming
increasingly important. Older adults exhibit not only
macronutrient deficiency but also micronutrient defi-
ciency because demands for vitamins, minerals, and trace
elements remain the same or are only slightly reduced in
older people [2]. Deficiencies in folic acid, vitamin D, cal-
cium, and vitamin B12 are especially prevalent [3,4]. Mal-
nutrition may have an impact on cognitive function and,* Correspondence: Christine.arnim@uni-ulm.de
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reproduction in any medium, provided the oramong patients with Alzheimer's disease (AD), cognitive
and functional capacities worsen more rapidly in those
who are most severely undernourished [5]. Several micro-
nutrients, in particular vitamins B6 and B12 and folic acid
with their effect on homocysteine (Hcy) metabolism [6-8],
as well as antioxidants [9,10], have been shown to be asso-
ciated with cognitive decline. Nevertheless, whether sup-
plementation with micronutrients is capable of reducing
the risk of dementia remains controversial [11-14]. Only a
few trials of micronutrient supplementation in those who
are cognitively impaired have been reported [15-18].
Little data is available regarding the absorption of nu-
tritional supplements and their measurable effects on
blood and tissue levels in elderly populations with mild
or moderate cognitive impairment. To describe vitamintral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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centrations; however, the information provided by these
measurements is limited because data about tissue vita-
min status are unreliable. Vitamin concentrations in
blood can vary significantly and can be influenced by
fasting, eating, or exercising [19-21]. Determination of
intracellular levels would thus be advantageous for
obtaining accurate knowledge about vitamin status.
Here we tested whether 2 months of micronutrient sup-
plementation with a freely accessible over-the-counter
supplement recommended for older adults leads to im-
proved blood and intracellular micronutrient status in per-
sons with mild or moderate cognitive impairment. As a
secondary hypothesis, we used the Mini Nutritional As-
sessment (MNA) to assess whether supplementation can
also improve general health and nutrition. To our know-
ledge, this is the first interventional trial in which novel
methods were used to measure tissue vitamin levels.
Methods
Study design
The study was designed as an open-label, exploratory
trial with micronutrient supplementation for 2 months
in cognitively impaired elderly persons.
Study population and baseline demographics
Forty-two (26 male [62%], 16 female [38%]) independently
living older patients on a home-prepared diet, aged 61–87
years (mean 70.6 years), were recruited from the Memory
Clinic of the University Hospital (Ulm, Germany), where
they had been referred because of memory concerns. All
participants were able to understand the implications and
procedures of the study and gave written informed consent.
Approval for this study was obtained from the ethics com-
mittee of the University of Ulm. Inclusion criteria were age
above 60 years and only mild or moderate cognitive impair-
ment. The study population had a Mini-Mental State
Examination (MMSE) average score of 24.17 ± 6.91 and a
Geriatric Depression Scale (GDS) average score of 3.26 ±
2.72. Anthropometric indicators included a mean baseline
body mass index (BMI) of 26.95 ± 3.45 and a mean body
weight of 76.15 ± 13.79. Exclusion criteria were acute ill-
ness, severe cognitive impairment, and severe depression.
Participants with additional vitamin supplementation prior
to study inclusion were excluded from the analysis of the
supplemented vitamin (retinol: two participants; vitamin E:
six; β-carotene, lutein, and lycopene: two; vitamin B1: two;
vitamin B6: three; vitamin B12: six; folic acid: five; zinc: five).
Participants were instructed to take one capsule of a micro-
nutrient supplement daily after breakfast for 2 months.
Composition of the micronutrient capsule
The micronutrient supplement (EunovaMultivitalstof-
feLangzeit 50; GlaxoSmithKline, Bühl, Germany) isrecommended for people aged ≥ 50 years and contains
vitamins, minerals, and trace elements (Additional file 1:
Table S1).
Procedures
Before and after supplementation, subjects underwent the
same examination procedures: blood and buccal mucosa
cells (BMC) were collected. Nutritional assessments,
MMSE, and GDS tests were administered. The partici-
pants were encouraged to maintain their dietary habits
during the study period. A compliance telephone call took
place 4–6 weeks after beginning the supplementation. Five
participants dropped out prior to follow-up, so that 37
subjects completed the entire study. At the second visit,
blisters were collected from the micronutrient supple-
ments and the number of tablets taken were counted: 29
participants took exactly 60 tablets, six took 59, and two
took 54, showing high compliance overall without signifi-
cant differences in intake. Therefore we assessed all 37
participants as one group.
Outcomes
The primary outcome was intracellular micronutrient
status in BMC as well as in blood. The secondary out-
come was assessment of general health and nutrition
using the MNA.
Collection of BMC and analysis of intracellular antioxidant
status
Collection of BMC was performed as described previously
[22] and samples were stored at −80°C. Vitamin concentra-
tions (vitamin E, lycopene, β-carotene) of the samples were
determined by BioTeSys GmbH (Esslingen, Germany)
using an accredited high-performance liquid chromatog-
raphy (HPLC) method in accordance with DIN EN ISO/
IEC 17025.
Sampling of blood and analytical methods
In addition to micronutrient blood levels, indirect
markers of vitamin B status were determined to assess
the metabolic effects of these vitamins. Subjects were
instructed not to take a capsule on the day of the second
examination, but did not fast because of the clinical set-
ting. In vitamin B12 deficiency, the serum concentra-
tions of methylmalonic acid (MMA) and Hcy increase.
Hcy is also an indicator of folic acid deficiency. Holo-
transcobalamin (TC) is the biologically available form of
vitamin B12 [23,24]. A decrease in erythrocyte trans-
ketolase activity (ETKA) [25] or an increase in ETKA
following stimulation with thiamine pyrophosphate
(TPP) in vitro (TPP effect) represent improved markers
for thiamine deficiency [26,27].
The levels of vitamins B1, B6, and B12; folic acid; zinc;
albumin; and Hcy were analyzed by the clinical laboratory
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lase, the TPP effect, holo-TC, and MMA were determined
by Synlab (Ulm, Germany). For determination of carot-
enoids, α-tocopherol, and retinol by HPLC, we used
the method proposed by Neal Craft [28]. For the meas-
urement of lutein, we used 8 μmol/L tocol as an internal
standard and performed the analysis with reversed-
phase HPLC in duplicate. For quantification, we used a
plasma pool that was calibrated with the international
certified standards from the National Institute of Stan-
dards and Technology.
Ascorbic acid (AA) and dehydroascorbic acid (DHA)
were analyzed by reversed-phase HPLC. First, the
plasma was thinned with 10% metaphosphoric acid 1:1
and then centrifuged (5 min, 4°C, 13000 g). The super-
natant fraction was separated into two parts. Tris(2-
chlorethyl)phosphate was added to one part to reduce
the DHA contained therein and the samples were centri-
fuged again. After this step, the concentration of AA and
total ascorbic acid (TAA = AA + DHA) could be de-
tected. For quantification, two additional vitamin C stan-
dards (100 μM and 50 μM) were used. All samples were
analyzed in duplicate. Reference values shown are in ac-
cordance with those from the respective laboratories or
from previous publications [29].
Assessment of nutritional status
To assess nutritional status, we determined both weight
and BMI and applied the MNA. The 18-item question-
naire was developed especially for older adults [30]. In
addition, we checked for general nutrition using a food
questionnaire (Hohenheimer Kurzfragebogen), which
showed no change in eating habits (Additional file 1:
Table S2), as well as by measurement of albumin (albu-
min [g/l] before: 40.00 +/− 2.83; after 40.60 +/− 2.76;
not significant). The MNA distinguishes three groups:
those who are well nourished (MNA score ≥23.5), those
with a risk of malnutrition (MNA score 17–23.5), and
those with malnutrition (MNA score <17). MNA was
performed in 41 participants before the study began and
in 36 participants at the end of the study. To compare
these scores, we included only those subjects with avail-
able MNA before and after supplementation.
Sample size and statistical analysis
This pilot study was undertaken to determine initial data
for the primary outcome measure in order to perform a
sample size calculation for a larger trial. Sample size was
therefore approximated by parameters to be estimated
and aimed to include >30 participants. The total sample
included 42 subjects before and 37 subjects after supple-
mentation. All data were analyzed with SPSS (version
15.0; SPSS Inc., Chicago, USA). Normal distribution was
checked by using a histogram and a q-q-plot. Whenthere was normal distribution, the paired-samples t-test
was used to detect significant differences in the same
group, and the Wilcoxon test was used when the values
had a skewed distribution. Additionally, Spearman’s cor-
relation coefficient was taken to identify associations
among the variables. P values < 0.05 were considered
statistically significant for all tests.
Results
Effect of vitamin supplementation on micronutrient
concentrations in blood and intracellular tissue
The first patient was enrolled in October 2008 and the
last patient finished the study in March 2009. After ex-
cluding subjects with prior additional vitamin supple-
ment use, we included those with a measured value
before and after supplementation for analysis. Table 1
summarizes micronutrient levels in blood before and
after supplementation. Most nutrients were well within
the reference ranges or above, suggesting no overt mal-
nutrition. However, before supplementation, seven par-
ticipants had α- and β-carotene concentrations below
the reference values. For zinc levels, 1 of 12 women
had a concentration below the reference, whereas 14
(77.8%) men had a zinc concentration below the refer-
ence value. No significant change in zinc, retinol, or
vitamin C was found after 2 months. A significant in-
crease in plasma concentration after supplementation
was, however, detected for α-carotene; β-carotene;
vitamin E; lutein; vitamins B1, B6, and B12; and folic
acid. After supplementation, all α-carotene levels were
in the normal range. Only three persons had β-carotene
levels below the reference value after supplementation.
Lower levels of lycopene concentration were seen after
supplementation, with the number of participants hav-
ing lycopene levels under the reference value doubling
afterward.
Table 2 shows the micronutrient concentrations in
BMC before (n = 42) and after (n = 37) supplementa-
tion. Samples with concentrations below the detection
level (n = 11) and with missing values (n = 24) before
supplementation were excluded. Therefore, only seven
patients were included for vitamin C analysis. We did
not find significant changes in micronutrient concentra-
tions in BMC. Of note, however, is that the number of
patients with concentrations of vitamin C above the de-
tection limit increased. Before supplementation, 11
(26.2%) subjects had a vitamin C concentration below
the detection level, whereas afterward all measured vita-
min C levels (n = 28) were above the detection level. To
assess the intracellular vitamin supply in B vitamin me-
tabolism, we analyzed specific metabolites; for vitamin
B12, TC and MMA were used. Hcy increases in intracel-
lular vitamin B6, vitamin B12, and folic acid deficiency.
Low ETKA and a high TPP effect are markers for
Table 1 Micronutrient levels in serum/plasma before and after supplementation are shown
Micronutrient Before [Mean ± SD] After [Mean ± SD] Reference value P-value
Vitamin C in plasma [μmol/L] N=31 61.22 ± 20.32 63.33 ± 12.0 45-80 n.s.
Vitamin A in plasma [μmol/L] N=35 2.21 ± 0.52 2.27 ± 0.40 > 1.05 n.s.
Vitamin E in plasma [μmol/L] N=31 36.55 ± 8.35 40.30 ± 8.68 > 16.2 p<0.05
α-Carotene in plasma [μmol/L] N=37 0.13 ± 0.12 0.15 ± 0.09 0.05–0.1 p<0.05
β-Carotene in plasma [μmol/L] N=35 0.58 ± 0.35 0.69 ± 0.47 0.3-0.6 p<0.01
Lutein in plasma [μmol/L] N=35 0.35 ± 0.16 0.40 ± 0.15 0.10–0.3 p<0.01
Lycopene in plasma [μmol/L] N=35 0.53 ± 0.22 0.45 ± 0.23 0.5–1.0 p<0.05
Vitamin B1 in serum [mmol/L] N=33 155.52 ± 49.22 187.73 ± 32.89 66–200 p<0.001
Vitamin B6 in serum [mmol/L] N= 32 83.72 ± 39.84 185.91 ± 65.56 35–110 p<0.001
Vitamin B12 in plasma [pmol/L] N=30 349.37 ± 117.08 382.40 ± 125.73 141–489 p<0.05
Folic acid in plasma [nmol/L] N=30 21.06 ± 8.64 39.8 ± 5.87 7–39.7 p<0.001
Zinc in plasma [μmol/L] N=12♀ / N=18♂ 11.34± 1.45♀ 11.36 ± 1.46♂ 11.83 ± 1.54♀ 11.03± 1.49♂ 9.0–22.0♀ 12.0–26.0♂ n.s.
n.s. = not significant.
♀ = female. ♂ = male.
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available vitamin B12, increased significantly (P < 0.01)
after supplementation (Table 3). Only two subjects had
an MMA concentration > 47 μg/L, indicating vitamin
B12 deficiency prior to supplementation. No significant
decrease in MMA levels after supplementation was de-
tected. After supplementation, Hcy levels decreased sig-
nificantly (P < 0.001). Before supplementation, plasma
levels of Hcy were elevated in 15 subjects, whereas after-
ward only five subjects had elevated Hcy concentrations.
Although there was no significant change in ETKA, the
decrease in the TPP effect was highly significant after
supplementation.
Effect of vitamin supplementation on nutritional and
health status
Nutritional data are shown in Table 4. None of the vol-
unteers was undernourished. Before supplementation, 25
(61%) subjects were well nourished, and 23 (63.9%) were
afterward. Sixteen (39%) subjects were at risk for malnu-
trition before supplementation and 13 (36.1%) afterward.
The risk for malnutrition was mainly attributable to a
poor subjective assessment of health status, selection of
food, or multi-medication. Comparison of the MNA
scores of all 36 volunteers revealed no significant changeTable 2 Micronutrients in cells of buccal mucosa before (B) an
Micronutrient Before (B) [Mean ± SD]
BMC-Vitamin C [pmol/μgDNA] N=7 9.01 ± 5.72
BMC-Vitamin E [pmol/μg DNA] N=30 24.77 ± 9.56
BMC-β-Carotin [pmol/μg DNA] N=24 0.45 ± 0.44
BMC-Lycopin [pmol/μg DNA] N=19 0.37 ± 0.16
n.s. = not significant, BMC = buccal mucosa cell.
Reference values are given as listed below. No significant difference after suppleme(B: 24.27 ± 2.38; A: 24.64 ± 2.28). However, when the
MNA scores of the well-nourished subjects and those at
risk for malnutrition were analyzed separately, the score
of the subjects at risk for malnutrition increased signifi-
cantly after supplementation (B: 21.93 ± 1.45; A: 22.75 ±
1.25; P < 0.05), whereas the scores of the well-nourished
subjects showed no difference (B: 25.76 ± 1.46; A: 25.84 ±
1.95). The MMSE scores were unchanged subsequent to
supplementation.
To analyze changes in health status by supplementa-
tion, the MNA asks how test persons consider their
health status in comparison with others of the same age.
After supplementation, none of the participants reported
their health status as “not as good,” whereas prior to
supplementation, four (11.1%) did so. Furthermore,
those who considered their health status as “better” in-
creased by 16.6% and those who considered it to be “as
good” decreased by approximately 8.3%. The improve-
ment of the subjectively assessed health status was also
the main reason why the subjects achieved better MNA
scores after supplementation.
Discussion
The purpose of this study was to assess the effect of a
typical micronutrient supplement on specific blood andd after (A) supplementation are shown
After (A) [Mean ± SD] Reference value p-value
11.76 ± 4.68 3.9–11.1 n.s.
26.45 ± 15.69 9.5–20.3 n.s.
0.40 ± 0.44 0.1–0.5 n.s.
0.33 ± 0.25 0.1–0.5 n.s.
ntation was seen.
Table 3 MMA, Holo-TC, Hcy, Transketolase, and the TPP-effect in serum/plasma before and after supplementation
Micronutrient Before (B) [Mean ± SD] After (A) [Mean ± SD] Reference value p-value
Methylmalonic acid [μg/L] N=32 27.11 ± 13.68 26.87 ± 14.56 <47 n.s.
Holo-Transcobalamin [pmol/L] N=32 53.59 ± 21.35 61.47 ± 23.40 19,1-119,3 p<0.01
Homocysteine [μmol/L] N=29 12.87 ± 4.24 9.65 ± 2.79 5-12 p<0.001
Transketolase [U/L] N=35 62.48 ± 16.85 58.89 ± 8.89 60-80 n.s.
TPP-Effect [%] N=35 12.61 ± 7.46 6.14 ± 3.92 <20 p<0.001
n.s. = not significant, TPP = thiamin pyrophosphate.
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general nutritional status (assessed by MNA) as the sec-
ondary outcome in cognitively impaired, independently
living older adults in a routine setting.
We did not see overt malnutrition in our patient popula-
tion; however, several epidemiological studies have shown
that in cognitive impairment and AD, lower levels of
micronutrients within the normal range are observed than
among controls, suggesting that there is an additional need
for specific micronutrients. For zinc, we observed a micro-
nutrient deficiency at baseline only in men. Our data show,
however, that a significant improvement in selected micro-
nutrients can be achieved after taking a micronutrient sup-
plement for 2 months.
Effect of vitamin supplementation on micronutrient
concentrations in blood and intracellular tissue
Our data are consistent with those of others in showing
decreased zinc levels in men with mild cognitive impair-
ment [31]. This could be explained by the fact that men
have a higher daily zinc requirement (10 mg/day) than
women (7 mg/day). Nonetheless, after supplementation,
plasma zinc levels did not increase. One possible reason
could be decreased zinc absorption efficiency in elderly
persons [32]. Inasmuch as a single capsule contains only
3.75 mg of zinc (54% of the daily requirement for
women and only 38% for men), this amount might not
be sufficient. A second explanation might be that the
study period (2 months) might have been too short for
zinc regarding its turnover time. One study has shown
that improving the zinc status of older adults (> 65
years) with low zinc levels by using a supplement (7 mg
zinc) for 1 year resulted not only in a decreasedTable 4 Nutritional status before and after supplementation
Micronutrient Before (B) n=41 [Mean ± SD]
Weight [kg] 76.15 ± 13.79
BMI [kg/m2] 26.95 ± 3.45
MNA [points]
Well-nourished 25.76 ± 1.46
Risk of malnutrition 21.93 ± 1.45
Undernutrition -
n.s. = not significant, BMI=Body mass index, MNA=Mini nutritional assessment.incidence and duration of pneumonia, but also in a de-
creased number of new antibiotic prescriptions and de-
creased total days of antibiotic use [33]. In addition,
normal baseline serum zinc concentrations were associ-
ated with a reduction in all causes of mortality.
In our study, the micronutrient status of vitamin E, β-
carotene, and lycopene in BMC was within normal limits
in most subjects before and after supplementation. With
regard to vitamin C, only seven BMC concentrations
were above detection levels despite normal vitamin C
values in plasma at baseline. After intervention, vitamin
C was above detection levels in all patients, indicating
that 150 mg (250% of recommended dietary allowance
[RDA]) is sufficient. The plasma and BMC concentra-
tions of β-carotene and lycopene were significantly cor-
related before and after supplementation. Similarly, a
study by Peng et al. also found a correlation between
these micronutrients in plasma and BMC [34]. On the
other hand, Pateau et al. found no correlation between
the lycopene concentration in plasma and BMC [35]. Be-
cause the recommended daily amount of β-carotene is
2–4 mg and no recommendation for lycopene exists,
and because the supplement contained only 0.5 mg of
carotenoids (<25% RDA), our data may support the need
for increased levels of carotenoids and lycopenes in sup-
plements. Plasma and BMC concentrations of vitamin E
were significantly correlated before supplementation,
similar to the findings reported in Peng et al. [34]. Fol-
lowing supplementation, this correlation was lacking, in-
dicating that BMC were completely saturated after
supplementation, whereas plasma concentration is not
saturable. This may suggest that the level of vitamin E in
the supplement with 200% RDA is more than sufficient.After (A) n=36 [Mean ± SD] p-value
76.41 ± 13.64 n.s.
27.06 ± 3.35 n.s.
25.84 ± 1.95 n.s.
22.75 ± 1.25 P <0.05
- n.s.
von Arnim et al. Nutrition Journal 2013, 12:148 Page 6 of 8
http://www.nutritionj.com/content/12/1/148Although the subjects had normal B vitamin levels in
blood, 15 (51.7%) displayed increased Hcy levels before
supplementation, indicating that blood levels of vitamin
B6, vitamin B12, and folic acid inadequately reflect intra-
cellular supply. We observed an improvement in B vita-
min status and a subsequent decrease in plasma Hcy.
Hcy is not only a risk factor for vascular disease, but also
for cognitive disorders [7]. Quadri et al. found an associ-
ation between dementia and hyperhomocysteinemia
[36]. Many studies found that elderly people in particu-
lar have a deficiency in their supplies of vitamin B12 and
folic acid [37]. In our study, most blood levels for vita-
mins B1, B6, and B12 and for folic acid were normal be-
fore supplementation. After supplementation, these
levels increased significantly. This is in line with the
amount of vitamins contained in the supplement itself:
B1 (200% RDA), B6 (>300% RDA), B12 (84% RDA), and
folic acid (125% RDA). Whereas there was no significant
change in the concentration of MMA, holo-TC in-
creased significantly (P < 0.01), indicating that the intra-
cellular status could still be optimized. Thus, an increase
in the amount of vitamin B12 in the supplement may
help to achieve better efficacy. However, analysis of the
required amount of supplementation requires further
study with several levels of supplementation.
Despite there being normal vitamin B1 concentrations
in the blood, the low ETKA in 18 (51.4%) subjects indi-
cated B1 deficiency in tissue. This finding was supported
by an elevated TPP effect of more than 20% in some of
our patients. Decreased ETKA might not be the best in-
dicator in the elderly population owing to apoenzyme
variations. In a study comparing ETKA and the TPP ef-
fect in healthy elderly subjects (70–82 years of age) with
those in young subjects (19–37 years of age), researchers
found that the older adults had a lower ETKA but a
similar TPP effect and erythrocyte thiamine levels [38].
Although the vitamin B1 concentration in blood in-
creased significantly (P < 0.001) after supplementation in
our study, ETKA did not increase. The TPP effect, how-
ever, decreased significantly, indicating improved intra-
cellular vitamin B1 status and confirming the superiority
of measuring the TPP effect.
Taken together, our results showed decreased Hcy levels,
a decreased TPP effect, and improved antioxidant status
after micronutrient supplementation. This might be helpful
for improving cognitive function. The FACIT study, which
showed beneficial effects on global cognitive function in
men and women (aged 50–70 years), achieved decreased
Hcy levels following 3-year supplementation with folic acid
[13]. A multivitamin, multimineral-enriched drink adminis-
tered over a 6-month period decreased Hcy levels, in-
creased B12 levels, and improved neuropsychological
performance in frail elderly persons (N = 101; age > 65
years; BMI <25) [39]. Supplementation with a multinutrientdrink for 12 weeks improved memory (delayed verbal re-
call) in patients with mild AD [15]. In our study, the period
of supplementation was probably too short to have a posi-
tive effect on cognition as measured by MMSE.
Effect of vitamin supplementation on nutritional and
health status
Micronutrient supplementation was associated with a sig-
nificant increase in the MNA score in persons at risk for
malnutrition. This improvement was mainly attributable to
improved self-perception of general health status after
micronutrient supplementation. The five dropouts in the
MNA analysis may also have affected this result, especially
considering the open-label character of the study. The
MNA is a well-established assessment tool for the identifi-
cation of patients at risk for malnutrition regardless of
cognitive condition [40] and has also been used in interven-
tional studies for follow-up evaluation [41,42]. The MNA
questions that showed significant intercorrelations in the
study by Soini et al. [42] formed logical patterns between
anthropometrics, decline in food intake with weight loss,
self-perceived nutritional status, the ability to eat, and the
use of fruit and vegetables. However, the results of the
MNA should not be overemphasized, because the aim of
this supplementation was not the improvement of energy
and protein deficiency. Other studies have shown that sub-
jective assessment of health does have predictive value [43].
Christensson et al. [44] concluded that “self-experienced
health status” has the greatest predictive value in MNA
classification. One reason they discussed was the possibility
of a reduced incidence of infections. Barringer et al. [45]
found a significantly reduced incidence of infections in pa-
tients with diabetes (age > 65) after 1 year of multivitamin
and mineral supplementation. In Christensson et al. [44],
quality of life was assessed as a secondary endpoint by the
Medical Outcomes Study 12-Item Short Form, which
showed no difference before and after supplementation. A
significant risk reduction for infections was shown after 18
months of multivitamin supplementation in a subgroup of
patients without dementia [46]. We did not assess infection
rate in the present study. We propose that in future trials,
an assessment for infections and for comprehensive quality
of life should be incorporated.
Strengths and limitations
The main strength of this study is its comprehensive ap-
proach for the determination of blood and intracellular
nutrient status, as well as assessment of metabolic
markers before and after supplementation, in addition to
general nutritional assessment. To our knowledge, the
comprehensive and innovative methods used herein for
micronutrient analysis are novel.
One limitation is that we did not analyze all of the
micronutrients contained in this trial supplement. In
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cause of the sample size. Moreover, without parallel con-
trols, the primary outcome could not be separated from a
time effect and the secondary outcome could not be sepa-
rated from a placebo effect. A major limitation regarding
self-assessed health status is the open-label character of
this study, which could have biased the subjective assess-
ment of the participants.
Conclusions
First, our data support the idea that micronutrient sup-
plements need to be carefully analyzed and adjusted for
specific groups. Our data indicate that vitamin B1, vita-
min B12, lycopene, and carotenoids should be given at
higher doses than used here to optimize their supply.
Second, placebo-controlled studies with longer periods
of micronutrient supplementation in elderly persons at
risk for malnutrition are required to further investigate
the effects of micronutrient supplements on nutritional
status and on quality of life.
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